Nuvation Bio Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $62.9 | $7.9 | $0.0 | — | — |
| Operating income | -$213.1 | -$592.6 | -$99.8 | -$119.7 | -$93.3 |
| Net income | -$204.6 | -$567.9 | -$75.8 | -$104.2 | -$86.8 |
Shares outstanding 351.1M · Free float 40.5%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.